GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | +10.0% | 512 | +9.4% | 0.02% | +23.1% |
| Q1 2022 | $20,000 | -25.9% | 468 | -24.4% | 0.01% | -23.5% |
| Q4 2021 | $27,000 | +8.0% | 619 | -6.9% | 0.02% | -5.6% |
| Q3 2021 | $25,000 | +31.6% | 665 | +37.7% | 0.02% | +28.6% |
| Q2 2021 | $19,000 | +11.8% | 483 | 0.0% | 0.01% | +7.7% |
| Q1 2021 | $17,000 | +21.4% | 483 | +21.1% | 0.01% | +8.3% |
| Q4 2020 | $14,000 | – | 399 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |